vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Planet Labs PBC（PL）财务数据对比。点击上方公司名可切换其他公司
Planet Labs PBC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$81.3M vs $75.5M），Planet Labs PBC同比增速更快（32.6% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $1.9M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 17.5%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Planet Labs PBC（常简称为Planet）是总部位于美国加利福尼亚州旧金山的上市地球影像企业，核心目标是实现全球范围的每日成像，以此监测地表变化、精准识别相关趋势，为多行业的地理数据分析需求提供可靠的数据支持。
PBYI vs PL — 直观对比
营收规模更大
PL
是对方的1.1倍
$75.5M
营收增速更快
PL
高出4.9%
27.7%
自由现金流更多
PBYI
多$12.5M
$1.9M
两年增速更快
PBYI
近两年复合增速
17.5%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $81.3M |
| 净利润 | — | $-59.2M |
| 毛利率 | 69.3% | 57.3% |
| 营业利润率 | 22.7% | -22.6% |
| 净利率 | — | -72.8% |
| 营收同比 | 27.7% | 32.6% |
| 净利润同比 | — | -194.7% |
| 每股收益（稀释后） | $0.26 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPL
| Q4 25 | $75.5M | $81.3M | ||
| Q3 25 | $54.5M | $73.4M | ||
| Q2 25 | $52.4M | $66.3M | ||
| Q1 25 | $46.0M | $61.6M | ||
| Q4 24 | $59.1M | $61.3M | ||
| Q3 24 | $80.5M | $61.1M | ||
| Q2 24 | $47.1M | $60.4M | ||
| Q1 24 | $43.8M | $58.9M |
净利润PBYIPL
| Q4 25 | — | $-59.2M | ||
| Q3 25 | $8.8M | $-22.6M | ||
| Q2 25 | $5.9M | $-12.6M | ||
| Q1 25 | $3.0M | $-35.2M | ||
| Q4 24 | — | $-20.1M | ||
| Q3 24 | $20.3M | $-38.7M | ||
| Q2 24 | $-4.5M | $-29.3M | ||
| Q1 24 | $-4.8M | $-30.1M |
毛利率PBYIPL
| Q4 25 | 69.3% | 57.3% | ||
| Q3 25 | 77.7% | 57.6% | ||
| Q2 25 | 76.5% | 55.2% | ||
| Q1 25 | 77.1% | 62.1% | ||
| Q4 24 | 76.4% | 61.2% | ||
| Q3 24 | 63.9% | 52.9% | ||
| Q2 24 | 77.4% | 52.4% | ||
| Q1 24 | 75.5% | 55.2% |
营业利润率PBYIPL
| Q4 25 | 22.7% | -22.6% | ||
| Q3 25 | 17.6% | -24.5% | ||
| Q2 25 | 12.7% | -34.4% | ||
| Q1 25 | 8.7% | -31.5% | ||
| Q4 24 | 22.6% | -36.9% | ||
| Q3 24 | 27.4% | -64.8% | ||
| Q2 24 | -4.6% | -57.2% | ||
| Q1 24 | -5.3% | -57.6% |
净利率PBYIPL
| Q4 25 | — | -72.8% | ||
| Q3 25 | 16.2% | -30.8% | ||
| Q2 25 | 11.2% | -19.1% | ||
| Q1 25 | 6.5% | -57.1% | ||
| Q4 24 | — | -32.8% | ||
| Q3 24 | 25.2% | -63.3% | ||
| Q2 24 | -9.6% | -48.5% | ||
| Q1 24 | -11.0% | -51.1% |
每股收益（稀释后）PBYIPL
| Q4 25 | $0.26 | $-0.19 | ||
| Q3 25 | $0.17 | $-0.07 | ||
| Q2 25 | $0.12 | $-0.04 | ||
| Q1 25 | $0.06 | $-0.12 | ||
| Q4 24 | $0.40 | $-0.07 | ||
| Q3 24 | $0.41 | $-0.13 | ||
| Q2 24 | $-0.09 | $-0.10 | ||
| Q1 24 | $-0.10 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $443.3M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $349.6M |
| 总资产 | $216.3M | $1.1B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIPL
| Q4 25 | $97.5M | $443.3M | ||
| Q3 25 | $94.4M | $181.1M | ||
| Q2 25 | $96.0M | $133.5M | ||
| Q1 25 | $93.2M | $118.0M | ||
| Q4 24 | $101.0M | $139.0M | ||
| Q3 24 | $96.7M | $148.3M | ||
| Q2 24 | $96.8M | $107.4M | ||
| Q1 24 | $107.2M | $83.9M |
总债务PBYIPL
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIPL
| Q4 25 | $130.3M | $349.6M | ||
| Q3 25 | $115.3M | $435.7M | ||
| Q2 25 | $104.7M | $444.8M | ||
| Q1 25 | $97.1M | $441.3M | ||
| Q4 24 | $92.1M | $464.6M | ||
| Q3 24 | $71.1M | $473.2M | ||
| Q2 24 | $48.5M | $500.3M | ||
| Q1 24 | $51.0M | $518.0M |
总资产PBYIPL
| Q4 25 | $216.3M | $1.1B | ||
| Q3 25 | $202.9M | $696.4M | ||
| Q2 25 | $194.9M | $658.4M | ||
| Q1 25 | $196.2M | $633.8M | ||
| Q4 24 | $213.3M | $630.8M | ||
| Q3 24 | $220.7M | $658.4M | ||
| Q2 24 | $205.0M | $674.6M | ||
| Q1 24 | $214.1M | $702.0M |
负债/权益比PBYIPL
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $28.6M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $1.9M |
| 自由现金流率自由现金流/营收 | 19.1% | 2.3% |
| 资本支出强度资本支出/营收 | 0.0% | 32.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $40.7M |
8季度趋势，按日历期对齐
经营现金流PBYIPL
| Q4 25 | $14.4M | $28.6M | ||
| Q3 25 | $9.7M | $67.8M | ||
| Q2 25 | $14.1M | $17.3M | ||
| Q1 25 | $3.6M | $-6.3M | ||
| Q4 24 | $15.6M | $4.1M | ||
| Q3 24 | $11.0M | $-7.9M | ||
| Q2 24 | $1.0M | $-4.3M | ||
| Q1 24 | $11.2M | $-6.8M |
自由现金流PBYIPL
| Q4 25 | $14.4M | $1.9M | ||
| Q3 25 | $9.7M | $47.5M | ||
| Q2 25 | $14.1M | $9.2M | ||
| Q1 25 | $3.6M | $-17.9M | ||
| Q4 24 | $15.6M | $-3.6M | ||
| Q3 24 | $11.0M | $-23.0M | ||
| Q2 24 | $1.0M | $-14.2M | ||
| Q1 24 | — | $-15.7M |
自由现金流率PBYIPL
| Q4 25 | 19.1% | 2.3% | ||
| Q3 25 | 17.7% | 64.7% | ||
| Q2 25 | 26.8% | 13.9% | ||
| Q1 25 | 7.7% | -29.1% | ||
| Q4 24 | 26.4% | -5.8% | ||
| Q3 24 | 13.7% | -37.6% | ||
| Q2 24 | 2.1% | -23.6% | ||
| Q1 24 | — | -26.7% |
资本支出强度PBYIPL
| Q4 25 | 0.0% | 32.9% | ||
| Q3 25 | 0.0% | 27.6% | ||
| Q2 25 | 0.0% | 12.3% | ||
| Q1 25 | 0.1% | 18.9% | ||
| Q4 24 | 0.0% | 12.5% | ||
| Q3 24 | 0.0% | 24.8% | ||
| Q2 24 | 0.0% | 16.4% | ||
| Q1 24 | 0.0% | 15.1% |
现金转化率PBYIPL
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
PL
| Defense And Intelligence | $49.4M | 61% |
| Civil Government | $18.8M | 23% |
| Commercial | $13.1M | 16% |
